Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients
Monica Benvenuto(University of Rome Tor Vergata), Roberto Bei(University of Rome Tor Vergata), Roberto Arriga(University of Rome Tor Vergata), Andrea Modesti(Immungenetics (Germany)), Giulia Lanzilli(Istituto di Farmacologia Traslazionale), Monica Nanni(University of California, San Francisco), Augusto Orlandi(University of Rome Tor Vergata), Vittorio Manzari, Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Giovanni Faggioni(Istituto Oncologico Veneto), Pierpaolo Sileri(Vita-Salute San Raffaele University), Luana Franceschilli(University of Rome Tor Vergata), Laura Masuelli(Sapienza University of Rome), Florigio Lista, Massimo Fantini(National Cancer Institute), Achille Gaspari(University of Rome Tor Vergata), P Rossi(University of Rome Tor Vergata)
Cited by 21
Related Papers
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
|Cancer Immunology Research|2015|456
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
|Journal of Clinical Medicine|2020|252
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory
|The Journal of Immunology|1995|179
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
|Arteriosclerosis Thrombosis and Vascular Biology|2006|158